| 2026-06-24 | Press release | Passage Bio and Remix Therapeutics Announce Merger Agreement |
| 2026-06-24 | Press release | Passage Bio and Remix Therapeutics Announce Merger Agreement |
| 2026-05-11 | Presentation | Download PDF
(opens in new window) |
| 2026-04-20 | Press release | Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates |
| 2026-04-20 | Press release | Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates |
| 2026-03-03 | Press release | Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights |
| 2026-02-19 | Press release | Passage Bio to Participate in Upcoming Investor Conferences |
| 2025-11-10 | Press release | Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights |
| 2025-11-05 | Press release | Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference |
| 2025-08-28 | Press release | Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference |
| 2025-08-12 | Press release | Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights |
| 2025-07-10 | Press release | Passage Bio Announces 1-for-20 Reverse Stock Split |
| 2025-06-23 | Press release | Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update |
| 2025-05-13 | Press release | Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights |
| 2025-05-09 | Presentation | ASGCT Poster: Scalable Production of an AAV Manufacturing Platform - Transitioning from Adherent to Suspension-Based Tri |
| 2025-04-03 | Presentation | AD/PD™ 2025 International Conference |
| 2025-03-04 | Press release | Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights |
| 2025-03-04 | Press release | Press Release |
| 2025-02-26 | Press release | Passage Bio to Participate in Upcoming Investor Conferences |
| 2025-01-10 | Press release | Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates |
| 2024-11-13 | Press release | Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights |
| 2024-11-13 | Press release | Press Release |
| 2024-11-06 | Press release | Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference |
| 2024-10-24 | Press release | Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell |
| 2024-09-23 | Press release | Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference |
| 2024-09-16 | Press release | Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International |
| 2024-09-10 | Press release | Passage Bio Welcomes Tom Kassberg to Board of Directors |
| 2024-08-30 | Press release | Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference |
| 2024-08-08 | Press release | Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights |
| 2024-08-08 | Press release | Press Release |
| 2024-08-06 | Press release | Passage Bio to Participate in Upcoming Investor Conferences |
| 2024-08-01 | Press release | Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collabor |
| 2024-07-16 | Press release | Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patient |
| 2024-06-05 | Press release | Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference |
| 2024-05-21 | Press release | Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award |
| 2024-05-14 | Press release | Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights |
| 2024-05-14 | Press release | Press Release |
| 2024-04-22 | Press release | Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit |
| 2024-03-05 | Press release | Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program |
| 2024-03-04 | Press release | Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights |